Colorado Cancer Clinical Trials
Search our team at AdventHealth Research Institute
Showing 1 - 4 of 4 clinical trials available
-
NCT07028853
A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF MEVROMETOSTAT (PF-06821497) WITH ENZALUTAMIDE IN METASTATIC CASTRATION-SENSITIVE PROSTATE CANCER
This study is currently enrolling.Associated Conditions: Urology of DenverResearch Area: Colorado Cancer ResearchResearch Location: Porter, Colorado -
NCT06492616
Elacestrant versus Standard Endocrine Therapy in Women and Men with Node-positive, Estrogen Receptor-positive, HER2-negative, Early Breast Cancer with High Risk of Recurrence - A Global, Multicenter, Randomized, Open-label Phase 3 Study (ELEGANT).
This study is currently enrolling.Associated Conditions: BreastResearch Area: Colorado Cancer ResearchResearch Location: Porter, ColoradoThe purpose of this clinical study is to test the safety and efficacy of elacestrant compared to standard of care therapy in participants with node-positive, estrogen receptor-positive (ER+), HER2... -
NCT05812807
OptimICE-PCR: De-Escalation of Therapy in Early-Stage TNBC Patients Who Achieve pCR After Neoadjuvant Chemotherapy with Checkpoint Inhibitor Therapy
This study is currently enrolling.Associated Conditions: BreastResearch Area: Colorado Cancer ResearchResearch Location: Porter, ColoradoThis study is being done to answer the following question: Among patients with early-stage TNBC who achieve a pCR after preoperative chemotherapy in combination with pembrolizumab, will observation... -
NCT02012699
Integrated Cancer Repository for Cancer Research
This study is currently enrolling.Associated Conditions: MultitherapeuticResearch Area: Colorado Cancer ResearchResearch Location: Porter, Colorado